Targeted alpha therapy (r)evolution : emerging nuclides for clinical applications
Source
Trends in pharmacological sciences - ISSN 0165-6147-47:3 (2026) p. 263-275
In vivo PET imaging of [鹿鈦窮]CHDI-385, a radioligand for mutant Huntingtin aggregates in a mouse model of Huntington disease
Source
The Journal of nuclear medicine - ISSN 0161-5505-67:2 (2026) p. 297-303
Design and evaluation of novel PET strategies to evaluate immunotherapy response
Source
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, 2026,235 p.
Rodent biodistribution and dosimetry of the PET radioligands [鹿鈦窮]CHDI-385 and [鹿鈦窮]CHDI-386 targeting mutant huntingtin aggregates
Source
Nuclear medicine and biology - ISSN 0969-8051-152 (2026) p. 1-8
In vitro kinetic profiling by enzymatic approaches to select FAPIs with a long residence time
Source
European journal of medicinal chemistry - ISSN 0223-5234-304 (2026) p. 1-19